NPI registry status
Active
2026 NPPES data Neuropathology Physician NPI 1487685384 M.D.
Verify on CMS → Kazim Sheikh, M.D.
Neuropathology Physician in Houston, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 335 in Neuropathology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
460
Medicare Part D claims · 69 beneficiaries · Neuropathology Physician avg: 365
Generic prescribing
70%
generic claims · 30% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
77.5/100
▼ 6 pts below national avg 83.5 · Above neutral
Industry payments
$494.36
20 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Kazim Sheikh, M.D. reported a CMS MIPS final score of 77.5/100 - below the 83.5 national average - and filed 460 Medicare Part D claims in 2024.
- 77.5/100
- MIPS score · -6 vs avg
- 460
- Part D claims, 2024
- 70%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Kazim Sheikh, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1487685384), first enumerated 07/06/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 460 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 77.5/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$494.36 in reported industry payments (20 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Kazim Sheikh, M.D.'s individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1487685384 · Neuropathology Physician
NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-BELOW · RX-LIGHT · BOOK-THIN · PHOTO-FINISH
- NPI-10 1487685384
- ENUM-LEGACY 2006
- TAX-TRACE 335
- MIPS-BELOW 77.5/100
- RX-LIGHT 460
- BOOK-THIN 30 in Texas
- PHOTO-FINISH Thomas Pearce, MD, PHD · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Rajnish Bharadwa…
Rajnish Bharadwaj, M.D.
76.8 MIPS pts
- Jeffrey Helgager…
Jeffrey Helgager, M.D., PH.D.
77.4 MIPS pts
- Sheikh · this pr…
Sheikh · this provider
77.5 MIPS pts
- Thomas Pearce, M…
Thomas Pearce, MD, PHD
77.5 MIPS pts
- Suash Sharma, M.…
Suash Sharma, M.D.
77.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Kazim Sheikh, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
78 ≥ 20th percentile 20% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
✓
Board certification likely (heuristic, not verified)
Kazim Sheikh, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Kazim Sheikh, M.D.?
Below national averagePrimary specialty
Neuropathology Physician
Medicare Part D claims
460 26% vs specialty avg
MIPS final score
77.5/100 6 pts vs avg
Specialty distribution in Texas
How Neuropathology Physician compares to other specialties among Texas providers
Medicare quality performance, MIPS
Kazim Sheikh, M.D.'s 2023 MIPS final score plotted against the Neuropathology Physician national average
- MIPS Final Score
- 77.5/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1487685384 |
|---|---|
| Specialty | Neuropathology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/06/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
77.5093
Final Score
Measured-score avg: 83.5
66.6499
Quality
50.9366
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Kazim Sheikh, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
UT Physicians
Houston, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Kazim Sheikh, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$494
Largest payer
ARGENX US, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Kazim Sheikh, M.D.. To verify Kazim Sheikh, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Kazim Sheikh, M.D. - brand share 30.0%
Neuropathology Physician average
30% brand-name claims vs 70% generic, on 460 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
460
Total Claims
$956K
Total Drug Cost
69
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 680.033
- Total Day Supply
- 18,258
- Brand vs Generic
- 30% brand / 70% generic
- Brand Drug Cost
- $938K
- Generic Drug Cost
- $18K
Patient Demographics
- Average Patient Age
- 69.1 years
- Avg HCC Risk Score
- 2.26
- Gender Split
- 51% female / 49% male
- Age Distribution
- <65: 15, 65-74: 33, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Kazim Sheikh, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Gabapentin
Gabapentin
50 claims
- Gamunex-C
Gamunex-C
44 claims
- Prednisone
Prednisone
41 claims
- Duloxetine Hcl
Duloxetine Hcl
34 claims
- Sodium Chloride
Sodium Chloride
29 claims
- Pyridostigmine Bro…
Pyridostigmine Bromide
28 claims
- Pyridostigmine Bro…
Pyridostigmine Bromide Er
27 claims
- Gammagard Liquid 17
Gammagard Liquid
17 claims
| Drug | Claims |
|---|---|
| Gabapentin | 50 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 44 |
| Prednisone | 41 |
| Duloxetine Hcl | 34 |
| Sodium Chloride 0.9 % Sodium Chloride | 29 |
| Pyridostigmine Bromide | 28 |
| Pyridostigmine Bromide Er Pyridostigmine Bromide | 27 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 17 |
| Gammaked Immune Globul G/Gly/Iga Avg 46 | 17 |
| Mycophenolate Mofetil | 15 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neuropathology Physician Overview
How Kazim Sheikh, M.D. fits within the Neuropathology Physician landscape nationally.
335
Neuropathology Physician Providers in US
43
States with Neuropathology Physician
365
Avg Claims per Provider
Kazim Sheikh, M.D.'s 460 claims are above the specialty average of 365.
Nationwide Neuropathology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Sheikh, both outside Texas so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (77.5 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Neuropathology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Sheikh.
One of 30 Neuropathology Physician providers enrolled in Texas, 5 are shown here.
Adekunle Adesina
MD PHD
Houston, TX
Dr. Dawna Armstrong
M.D.
Conroe, TX
Dr. Meenakshi Bhattacharjee
MD
Houston, TX
Dr. Janet Bruner
M.D.
Houston, TX
Dr. Dennis Burns
MD
Dallas, TX
Compare Neuropathology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Kazim Sheikh, M.D.'s specialty? ▼
Kazim Sheikh, M.D. specializes in Neuropathology Physician and practices in Houston, Texas. Credentials: M.D..
How much does Kazim Sheikh, M.D. prescribe under Medicare Part D? ▼
In 2024, Kazim Sheikh, M.D. wrote 460 Medicare Part D claims totaling $956K in drug costs for 69 beneficiaries.
What is Kazim Sheikh, M.D.'s Medicare quality score? ▼
Kazim Sheikh, M.D. has a CMS MIPS Final Score of 77.5/100 (Quality: 66.6, Cost: 50.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Kazim Sheikh, M.D. located? ▼
Kazim Sheikh, M.D. is located at 6410 FANNIN ST, Houston, TX, 77030. Phone: (832) 325-7084.
What is Kazim Sheikh, M.D.'s NPI number? ▼
Kazim Sheikh, M.D.'s National Provider Identifier (NPI) is 1487685384, issued on 07/06/2006.
Does Kazim Sheikh, M.D. prescribe more brand-name or generic drugs? ▼
Kazim Sheikh, M.D.'s prescribing is 30% brand-name and 70% generic drugs by claim count, with $938K in brand drug costs.
How many Neuropathology Physician providers are there in the US? ▼
There are 335 Neuropathology Physician providers across 43 states in the US. The average Neuropathology Physician provider writes 365 Medicare Part D claims per year.
What drugs does Kazim Sheikh, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Kazim Sheikh, M.D.'s most frequently prescribed drugs include Gabapentin, Gamunex-C, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Kazim Sheikh, M.D. accept Medicare? ▼
Kazim Sheikh, M.D. appears in CMS Medicare data with 460 Part D claims and 69 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Kazim Sheikh, M.D.'s credentials? ▼
Kazim Sheikh, M.D.'s NPI is 1487685384 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.